SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3woz'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)	View	Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MX1_B_THAB2_1 (LIVER CARBOXYLESTERASE I)	3woz	CLIP-ASSOCIATING PROTEIN 2 (Mus musculus)	5 / 11	LEU A 711 PHE A 707 LEU A 722 LEU A 685 LEU A 729	None	1.21A	1mx1B-3wozA: undetectable	1mx1B-3wozA: 18.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HW2_A_RFPA1200_1 (RIFAMPIN ADP-RIBOSYL TRANSFERASE)	3woz	CLIP-ASSOCIATING PROTEIN 2 (Mus musculus)	5 / 12	PHE A 848 ALA A 813 THR A 773 GLY A 862 LEU A 866	None	1.07A	2hw2A-3wozA: undetectable	2hw2A-3wozA: 20.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PKK_A_2FAA501_2 (ADENOSINE KINASE)	3woz	CLIP-ASSOCIATING PROTEIN 2 (Mus musculus)	4 / 4	ALA A 863 VAL A 817 PHE A 859 THR A 822	None	1.28A	2pkkA-3wozA: undetectable	2pkkA-3wozA: 19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2W1B_A_DXCA2034_0 (ACRIFLAVIN RESISTANCE PROTEIN B)	3woz	CLIP-ASSOCIATING PROTEIN 2 (Mus musculus)	3 / 3	PHE A 766 SER A 839 LEU A 837	None	0.82A	2w1bA-3wozA: undetectable	2w1bA-3wozA: 12.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NDI_A_SAMA601_0 (METHYLTRANSFERASE)	3woz	CLIP-ASSOCIATING PROTEIN 2 (Mus musculus)	5 / 12	PHE A 848 GLU A 793 ILE A 792 PHE A 804 ALA A 832	None	1.36A	3ndiA-3wozA: undetectable	3ndiA-3wozA: 20.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X23_A_LSNA502_1 (CYTOCHROME P450 2C9)	3woz	CLIP-ASSOCIATING PROTEIN 2 (Mus musculus)	5 / 12	ALA A 796 PHE A 804 ALA A 813 LEU A 855 LEU A 851	None	0.99A	5x23A-3wozA: undetectable	5x23A-3wozA: 19.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6IBL_A_H98A501_0 (THIOREDOXIN 1,BETA-1 ADRENERGIC RECEPTOR)	3woz	CLIP-ASSOCIATING PROTEIN 2 (Mus musculus)	5 / 12	THR A 810 VAL A 814 VAL A 817 ASP A 803 PHE A 804	None	0.79A	6iblA-3wozA: undetectable	6iblA-3wozA: 21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6IBL_B_H98B501_0 (THIOREDOXIN 1,BETA-1 ADRENERGIC RECEPTOR)	3woz	CLIP-ASSOCIATING PROTEIN 2 (Mus musculus)	5 / 12	THR A 810 VAL A 814 VAL A 817 ASP A 803 PHE A 804	None	0.82A	6iblB-3wozA: undetectable	6iblB-3wozA: 21.96

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1MX1_B_THAB2_1","LIVER CARBOXYLESTERASE I","3woz","CLIP-ASSOCIATING PROTEIN 2","Mus musculus",5,"LEU A 711;PHE A 707;LEU A 722;LEU A 685;LEU A 729","None","1.21A","1mx1B-3wozA:undetectable","1mx1B-3wozA:18.71"],["2HW2_A_RFPA1200_1","RIFAMPIN ADP-RIBOSYL TRANSFERASE","3woz","CLIP-ASSOCIATING PROTEIN 2","Mus musculus",5,"PHE A 848;ALA A 813;THR A 773;GLY A 862;LEU A 866","None","1.07A","2hw2A-3wozA:undetectable","2hw2A-3wozA:20.78"],["2PKK_A_2FAA501_2","ADENOSINE KINASE","3woz","CLIP-ASSOCIATING PROTEIN 2","Mus musculus",4,"ALA A 863;VAL A 817;PHE A 859;THR A 822","None","1.28A","2pkkA-3wozA:undetectable","2pkkA-3wozA:19.54"],["2W1B_A_DXCA2034_0","ACRIFLAVIN RESISTANCE PROTEIN B","3woz","CLIP-ASSOCIATING PROTEIN 2","Mus musculus",3,"PHE A 766;SER A 839;LEU A 837","None","0.82A","2w1bA-3wozA:undetectable","2w1bA-3wozA:12.99"],["3NDI_A_SAMA601_0","METHYLTRANSFERASE","3woz","CLIP-ASSOCIATING PROTEIN 2","Mus musculus",5,"PHE A 848;GLU A 793;ILE A 792;PHE A 804;ALA A 832","None","1.36A","3ndiA-3wozA:undetectable","3ndiA-3wozA:20.05"],["5X23_A_LSNA502_1","CYTOCHROME P450 2C9","3woz","CLIP-ASSOCIATING PROTEIN 2","Mus musculus",5,"ALA A 796;PHE A 804;ALA A 813;LEU A 855;LEU A 851","None","0.99A","5x23A-3wozA:undetectable","5x23A-3wozA:19.33"],["6IBL_A_H98A501_0","THIOREDOXIN 1,BETA-1 ADRENERGIC RECEPTOR","3woz","CLIP-ASSOCIATING PROTEIN 2","Mus musculus",5,"THR A 810;VAL A 814;VAL A 817;ASP A 803;PHE A 804","None","0.79A","6iblA-3wozA:undetectable","6iblA-3wozA:21.96"],["6IBL_B_H98B501_0","THIOREDOXIN 1,BETA-1 ADRENERGIC RECEPTOR","3woz","CLIP-ASSOCIATING PROTEIN 2","Mus musculus",5,"THR A 810;VAL A 814;VAL A 817;ASP A 803;PHE A 804","None","0.82A","6iblB-3wozA:undetectable","6iblB-3wozA:21.96"]]